Evidence map›Paper›PMID 37831711›Full record

ArticlePloS one2023

Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults.

Ariana Saatchi, Jennifer N Reid, Salimah Z Shariff, Marcus Povitz, Michael Silverman, David M Patrick, Andrew M Morris, James McCormack, Manon R Haverkate, Fawziah Marra

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ariana SaatchiFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Jennifer N ReidICES Western, Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada.
Salimah Z ShariffICES Western, Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada.
Marcus PovitzDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Michael SilvermanFaculty of Medicine, Western University, London, Ontario, Canada.
David M PatrickBritish Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Andrew M MorrisSinai Health System, University Health Network and University of Toronto, Toronto, Ontario, Canada.
James McCormackFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Manon R HaverkateFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Fawziah MarraFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-1266-1901
University of British Columbia · CALawson Health Research Institute · CAUniversity Health Network · CAUniversity of Calgary · CAWestern University · CA

Funding

CIHR 201809-408648
6 · The paper itself

Abstract

backgroundThis retrospective cohort study is the first in North America to examine population-level appropriate antibiotic use for community-acquired pneumonia (CAP) in older adults, by agent, dose and duration. With the highest rates of CAP reported in the elderly populations, appropriate antibiotic use is essential to improve clinical outcomes. Given the ongoing crisis of antimicrobial resistance, understanding inappropriate antibiotic prescribing is integral to direct community stewardship efforts.

methodsAll outpatient primary care visits for CAP (aged ≥65 years) were identified using physician billing codes between January 1 2014 to December 31 2018 in British Columbia (BC) and Ontario (ON). Categories of prescribing were derived from existing literature, and constructed for clinical relevance using Canadian and international guidelines available during the study period. Categories were mutually exclusive and included: guideline adherent (first-line agent, adherent dose/duration), clinically appropriate (non-first line agent, presence of comorbidities), effective but unnecessary (first-line agent, excess dose/duration), undertreatment (first-line agent, subtherapeutic dose/duration), and not recommended (non-first line agent, absence of comorbidities). Proportions of prescribing were examined by category. Temporal trends in prescribing were examined using Poisson regression.

resultsA total of 436,441 episodes of CAP were identified, with 46% prescribed an antibiotic in BC, and 52% in Ontario. Guideline adherent prescribing was minimal for both provinces (BC: 2%; ON: 1%) however the largest magnitude of increase was reported in this category by the final study year (BC-Rate Ratio [RR]: 3.4, 95% Confidence Interval [CI]: 2.7-4.3; ON-RR: 4.62, 95% CI: 3.4-6.5). Clinically appropriate prescribing accounted for the most antibiotics issued, across all study years (BC: 61%; ON: 74%) (BC-RR: 0.8, 95% CI: 0.8-0.8; ON-RR: 0.9, 95% CI: 0.8-0.9). Excess duration of therapy was the hallmark characteristic for effective but unnecessary prescribing (BC: 92%; ON: 99%). The most common duration prescribed was 7 days, followed by 10. Not recommended prescribing was minimal in both provinces (BC: 4%; ON: 7%) and remained stable by the final study year (BC-RR: 1.1, 95% CI: 0.9-1.2; ON-RR: 0.9, 95% CI: 0.9-1.1).

conclusionThree quarters of antibiotic prescribing for CAP was appropriate in Ontario, but only two thirds in BC. Shortening durations-in line with evidence for 3 to 5-day treatment presents a focused target for stewardship efforts.

Indexed as

Community-Acquired InfectionsPneumoniaAgedAnti-Bacterial AgentsCohort StudiesHumansInappropriate PrescribingOntarioOutpatientsPractice Patterns, Physicians'Retrospective StudiesAnti-Bacterial Agents

Identifiers

PMID37831711
PMCPMC10575505
OpenAlexW4387636926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.